These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24363035)
1. Quality of life in adult patients with glycogen storage disease type I: results of a multicenter italian study. Sechi A; Deroma L; Paci S; Lapolla A; Carubbi F; Burlina A; Rigoldi M; Di Rocco M JIMD Rep; 2014; 14():47-53. PubMed ID: 24363035 [TBL] [Abstract][Full Text] [Related]
2. Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. Sechi A; Deroma L; Lapolla A; Paci S; Melis D; Burlina A; Carubbi F; Rigoldi M; Di Rocco M J Inherit Metab Dis; 2013 Jan; 36(1):83-9. PubMed ID: 22562700 [TBL] [Abstract][Full Text] [Related]
3. Psychosocial functioning in youth with glycogen storage disease type I. Storch E; Keeley M; Merlo L; Jacob M; Correia C; Weinstein D J Pediatr Psychol; 2008 Aug; 33(7):728-38. PubMed ID: 18296725 [TBL] [Abstract][Full Text] [Related]
4. Glycogen storage disease in adults. Talente GM; Coleman RA; Alter C; Baker L; Brown BI; Cannon RA; Chen YT; Crigler JF; Ferreira P; Haworth JC; Herman GE; Issenman RM; Keating JP; Linde R; Roe TF; Senior B; Wolfsdorf JI Ann Intern Med; 1994 Feb; 120(3):218-26. PubMed ID: 8273986 [TBL] [Abstract][Full Text] [Related]
5. Impact of glycogen storage disease type I on adult daily life: a survey. Garbade SF; Ederer V; Burgard P; Wendel U; Spiekerkoetter U; Haas D; Grünert SC Orphanet J Rare Dis; 2021 Sep; 16(1):371. PubMed ID: 34479584 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500 [TBL] [Abstract][Full Text] [Related]
8. Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases. Liang Y; Du C; Wei H; Zhang C; Zhang M; Hu M; Fang F; Luo X Mol Genet Genomic Med; 2020 Oct; 8(10):e1444. PubMed ID: 32772503 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I. Ross KM; Brown LM; Corrado MM; Chengsupanimit T; Curry LM; Ferrecchia IA; Porras LY; Mathew JT; Weinstein DA JIMD Rep; 2016; 26():85-90. PubMed ID: 26303612 [TBL] [Abstract][Full Text] [Related]
11. Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants. Skakic A; Djordjevic M; Sarajlija A; Klaassen K; Tosic N; Kecman B; Ugrin M; Spasovski V; Pavlovic S; Stojiljkovic M Clin Genet; 2018 Feb; 93(2):350-355. PubMed ID: 28685844 [TBL] [Abstract][Full Text] [Related]
12. Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy. Okechuku GO; Shoemaker LR; Dambska M; Brown LM; Mathew J; Weinstein DA J Inherit Metab Dis; 2017 Sep; 40(5):703-708. PubMed ID: 28612263 [TBL] [Abstract][Full Text] [Related]
13. Utilization of cornstarch in glycogen storage disease type Ia. Bodamer OA; Feillet F; Lane RE; Lee PJ; Dixon MA; Halliday D; Leonard JV Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1251-6. PubMed ID: 12439121 [TBL] [Abstract][Full Text] [Related]
14. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. Visser G; Rake JP; Fernandes J; Labrune P; Leonard JV; Moses S; Ullrich K; Smit GP J Pediatr; 2000 Aug; 137(2):187-91. PubMed ID: 10931410 [TBL] [Abstract][Full Text] [Related]
15. Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib. Sarajlija A; Djordjevic M; Kecman B; Skakic A; Pavlovic S; Pasic S; Stojiljkovic M Eur J Med Genet; 2020 Mar; 63(3):103767. PubMed ID: 31536830 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy for type I glycogen storage diseases. Chou JY; Mansfield BC Curr Gene Ther; 2007 Apr; 7(2):79-88. PubMed ID: 17430128 [TBL] [Abstract][Full Text] [Related]
17. Molecular biology and gene therapy for glycogen storage disease type Ib. Chou JY; Cho JH; Kim GY; Mansfield BC J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270 [TBL] [Abstract][Full Text] [Related]
18. [Quality of life of patients with gallstone disease and gallbladder cholesterosis in the conservative and surgical treatment]. Ivanchenkova RA; At'kova ER Eksp Klin Gastroenterol; 2012; (5):46-55. PubMed ID: 23402171 [TBL] [Abstract][Full Text] [Related]
19. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. Brooks ED; Landau DJ; Everitt JI; Brown TT; Grady KM; Waskowicz L; Bass CR; D'Angelo J; Asfaw YG; Williams K; Kishnani PS; Koeberl DD J Inherit Metab Dis; 2018 Nov; 41(6):965-976. PubMed ID: 30043186 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire. Uchmanowicz I; Jankowska-Polańska B; Wleklik M; Rosinczuk-Tonderys J; Dębska G Pneumonol Alergol Pol; 2014; 82(1):10-7. PubMed ID: 24391066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]